Anterix (ATEX) Cash & Equivalents (2013 - 2026)

Anterix (ATEX) has reported Cash & Equivalents for 14 consecutive years, with $98.5 million the latest figure, recorded in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $98.5 million, up 107.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $98.5 million (up 107.99% YoY), and the FY2026 annual result was $98.5 million, up 107.99% from the prior year.
• Cash & Equivalents was $98.5 million for Q1 2026 at Anterix, up from $29.5 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $105.6 million in Q1 2022 and troughed at $28.8 million in Q4 2024.
• Average Cash & Equivalents over 5 years is $55.4 million, with a median of $48.5 million recorded in 2023.
• Year-over-year, Cash & Equivalents plunged 66.42% in 2023 and jumped 107.99% in 2026.
• Over 5 years, Cash & Equivalents stood at $57.5 million in 2022, then rose by 7.86% to $62.0 million in 2023, then tumbled by 53.58% to $28.8 million in 2024, then increased by 2.56% to $29.5 million in 2025, then surged by 233.63% to $98.5 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $98.5 million in Q1 2026, $29.5 million in Q4 2025, and $39.1 million in Q3 2025.